JPRN-UMIN000027026已完成未知
Oral beclomethasone dipropionate treatment for gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation - Oral beclomethasone dipropionate treatment for gastrointestinal GVHD after allo-HSCT
Tokyo Women's Medical University, Department of Hematology0 个研究点目标入组 5 人开始时间: 2017年4月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Cases who can not be collected data. 2. Patients whose research managers judged inappropriate as subjects. 3. Patients who had requested refusal to investigate.
研究者
相似试验
已完成
不适用
Oral Beclometasone dipropionate for for gut GVHDGut Graft-versus-host diseaseJPRN-UMIN000031703Department of Pediatrics, University of Ryukyus, hospital1
已完成
不适用
The efficacy and safety of oral Beclomethasone dipropionate (BDP) in patients with gastrointestinal acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation FBMTG BDP17Hematologic disorders Gastrointestinal acute GVHDJPRN-UMIN000025116FBMTG35
已完成
不适用
The efficacy and safety of oral Beclomethasone dipropionate (BDP) in patients with gastrointestinal acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantatioHematologic disorders Gastrointestinal acute GVHDJPRN-UMIN000010750Fukuoka Blood and Marrow Transplantation Group35
进行中（未招募）
不适用
Efficacy and safety of Beclomethasone dipropionate, gastro-resistant, prolonged release tablets (CHF1514) compared to oral prednisone, in a 8-week treatment period, in patients with active ulcerative colitis. An international, multicentre, randomized, double blind, parallel group study. - Beta studylcerative colitis extending proximally beyond the rectum.MedDRA version: 9.1Level: LLTClassification code 10045365Term: Ulcerative colitisEUCTR2006-004230-32-BECHIESI Farmaceutici S.p.A.300
已完成
不适用
Efficacy and safety of Beclomethasone dipropionate, gastro-resistant, prolonged release tablets (CHF1514) compared to oral prednisone, in a 8-week treatment period, in patients with active ulcerative colitis. An international, multicentre, randomized, double blind, parallel group study.Mild to moderate Ulcerative colitisOral and Gastrointestinal - Inflammatory bowel diseaseACTRN12609001010280Chiesi Farmaceutici S.p.A.244